Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer

[1]  P. Prandoni,et al.  An association between residual vein thrombosis and subclinical atherosclerosis: Cross-sectional study. , 2017, Thrombosis research.

[2]  F. Pomero,et al.  Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study , 2017, Journal of thrombosis and haemostasis : JTH.

[3]  F. Dentali,et al.  Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism , 2017, Journal of thrombosis and haemostasis : JTH.

[4]  S. Kahn,et al.  Long‐term outcomes of cancer‐related isolated distal deep vein thrombosis: the OPTIMEV study , 2017, Journal of thrombosis and haemostasis : JTH.

[5]  M. Righini,et al.  Management of distal deep vein thrombosis. , 2017, Thrombosis research.

[6]  G. Lessiani,et al.  Ultrasound Characteristics of Calf Deep Vein Thrombosis and Residual Vein Obstruction After Low Molecular Weight Heparin Treatment. , 2016, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[7]  G. Heinze,et al.  The long‐term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study , 2016, Journal of thrombosis and haemostasis : JTH.

[8]  Elie A Akl,et al.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. , 2012, Chest.

[9]  J. Heit.  Epidemiology of venous thromboembolism , 2015, Nature Reviews Cardiology.

[10]  W. Ageno,et al.  Optimal duration of low molecular weight heparin for the treatment of cancer-related deep vein thrombosis: the Cancer-DACUS Study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  S. Kahn,et al.  Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis , 2014, Journal of thrombosis and haemostasis : JTH.

[12]  G. Palareti.  How I treat isolated distal deep vein thrombosis (IDDVT). , 2014, Blood.

[13]  J. Douketis,et al.  Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis , 2013, Thrombosis and Haemostasis.

[14]  P. Wells,et al.  Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta‐analysis , 2011, Journal of thrombosis and haemostasis : JTH.

[15]  B. Cosmi,et al.  D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis , 2011, Thrombosis and Haemostasis.

[16]  R. Abbate,et al.  Combination of D‐dimer, F1+2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal , 2008, Journal of thrombosis and haemostasis : JTH.

[17]  H. Büller,et al.  Acquired and Inherited Thrombophilic Factors and the Risk for Residual Venous Thrombosis , 2003, Pathophysiology of Haemostasis and Thrombosis.

[18]  P Prandoni,et al.  A Simple Ultrasound Approach for Detection of Recurrent Proximal‐Vein Thrombosis , 1993, Circulation.